Showing results (111-120 of 313) with videos related to
Sort By:
Pageof 32
Cancer|June 22, 2011
Cytogenetic profile of patients with acute myeloid leukemia and central nervous system diseaseFerial Shihadeh, Valerie Reed, Stefan Faderl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Pregnancy among patients with chronic myeloid leukemia treated with imatinibPatricia Ault, Hagop Kantarjian, Susan O'Brien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemiaXavier C Badoux, Michael J Keating, Sijin Wen, et al.Cancer|December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimensDushyant Verma, Susan O'Brien, Deborah Thomas, et al.Cancer|September 7, 2006
Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.Cancer|March 8, 2007
Outcome of patients with Philadelphia chromosome-positive chronic myelogenous leukemia post-imatinib mesylate failureHagop Kantarjian, Susan O'Brien, Moshe Talpaz, et al.Cancer|September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 yearsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.Leukemia Research|May 15, 2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemiaFarhad Ravandi, Jorge Cortes, Zeev Estrov, et al.Blood|August 2, 2011
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitorsElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.Leukemia Research|November 3, 2009
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapseFarhad Ravandi, Hagop Kantarjian, Stefan Faderl, et al.Pageof 32